Tech Company Financing Transactions
Daye Funding Round
Daye closed a $11.5 million Series A financing round on 10/26/2022. Investors included Cross Border Impact Ventures, Hambro Perks and private investors.
Transaction Overview
Company Name
Announced On
10/26/2022
Transaction Type
Venture Equity
Amount
$11,540,000
Round
Series A
Investors
private investors (Fiona Pathiraja)
private investors (Michelle Tempest)
Proceeds Purpose
The company intends to use the funds to launch its tampon-based at-home vaginal microbiome screening kit, to roll out a digital platform for gynae health, and kickstart its launch in the U.S.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Unit 113, Jam Studios The Biscuit Factory, 100 Drummond
London England, SE16 4DG
UK
London England, SE16 4DG
UK
Phone
Undisclosed
Website
Email Address
Overview
Daye exists to bridge the gender gap in medical research and innovation. Manufacturer of cramp-fighting CBD tampons intended to assist in tackling dysmenorrhea. The company's tampons are an alternative to traditional painkillers as well as more hygienic and sustainable than legacy tampons, enabling women to overcome the pain during their periods.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Benjamin Adams
Founder
Valentina Milanova
Browse more venture capital transactions:
Prev: 10/26/2022: QuantHealth venture capital transaction
Next: 10/26/2022: Penny Black venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs